medifast inc. - MED

MED

Close Chg Chg %
10.10 0.26 2.57%

Closed Market

10.36

+0.26 (2.57%)

Volume: 159.70K

Last Updated:

Apr 2, 2026, 3:59 PM EDT

Company Overview: medifast inc. - MED

MED Key Data

Open

$10.06

Day Range

10.00 - 10.36

52 Week Range

9.22 - 15.46

Market Cap

$113.87M

Shares Outstanding

10.99M

Public Float

10.63M

Beta

0.56

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.70

Yield

0.00%

Dividend

$1.65

EX-DIVIDEND DATE

Sep 18, 2023

SHORT INTEREST

N/A

AVERAGE VOLUME

281.73K

 

MED Performance

1 Week
 
6.26%
 
1 Month
 
-3.81%
 
3 Months
 
-0.38%
 
1 Year
 
-21.46%
 
5 Years
 
-95.34%
 

MED Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About medifast inc. - MED

Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. It offers and ships OPTAVIA products directly to its customers. It focuses on coaching healthy habits through a health transformational system. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD.

MED At a Glance

Medifast, Inc.
1501 South Clinton Street
Baltimore, Maryland 21224
Phone 1-410-581-8042 Revenue 385.79M
Industry Miscellaneous Commercial Services Net Income -18,672,000.00
Sector Commercial Services Employees 380
Fiscal Year-end 12 / 2026
View SEC Filings

MED Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.304
Price to Book Ratio 0.59
Price to Cash Flow Ratio 17.09
Enterprise Value to EBITDA 10.585
Enterprise Value to Sales -0.102
Total Debt to Enterprise Value -0.272

MED Efficiency

Revenue/Employee 1,015,231.579
Income Per Employee -49,136.842
Receivables Turnover N/A
Total Asset Turnover 1.402

MED Liquidity

Current Ratio 4.694
Quick Ratio 4.224
Cash Ratio 3.894

MED Profitability

Gross Margin 71.331
Operating Margin -3.684
Pretax Margin -1.462
Net Margin -4.84
Return on Assets -6.787
Return on Equity -9.13
Return on Total Capital -8.908
Return on Invested Capital -8.786

MED Capital Structure

Total Debt to Total Equity 5.376
Total Debt to Total Capital 5.102
Total Debt to Total Assets 4.161
Long-Term Debt to Equity 3.062
Long-Term Debt to Total Capital 2.906
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Medifast Inc. - MED

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.60B 1.07B 602.46M 385.79M
Sales Growth
+4.75% -32.94% -43.80% -35.96%
Cost of Goods Sold (COGS) incl D&A
445.96M 296.20M 157.84M 110.60M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
17.08M 17.71M 17.40M 10.50M
Depreciation
14.00M 14.61M 17.40M 10.50M
Amortization of Intangibles
- - 3.08M 3.11M
-
COGS Growth
+11.91% -33.58% -46.71% -29.93%
Gross Income
1.15B 775.85M 444.62M 275.19M
Gross Income Growth
+2.22% -32.69% -42.69% -38.11%
Gross Profit Margin
+72.10% +72.37% +73.80% +71.33%
2022 2023 2024 2025 5-year trend
SG&A Expense
936.61M 649.45M 441.75M 289.40M
Research & Development
4.50M 4.60M 4.60M 4.30M
Other SG&A
932.11M 644.85M 437.14M 285.10M
SGA Growth
+2.77% -30.66% -31.98% -34.49%
Other Operating Expense
- - - -
-
Unusual Expense
- 31.20M 4.09M (17.00K)
EBIT after Unusual Expense
184.81M 126.40M (1.21M) (14.20M)
Non Operating Income/Expense
(46.00K) 2.40M 5.00M 8.56M
Non-Operating Interest Income
- 2.49M 4.80M 5.52M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 701.00K
-
Interest Expense Growth
- - +203.46% -100.00%
-
Gross Interest Expense
- - - 701.00K
-
Interest Capitalized
- - - -
-
Pretax Income
184.06M 128.80M 3.79M (5.64M)
Pretax Income Growth
-14.84% -30.02% -97.06% -248.90%
Pretax Margin
+11.51% +12.01% +0.63% -1.46%
Income Tax
40.49M 29.38M 1.70M 13.03M
Income Tax - Current - Domestic
41.41M 28.17M 9.10M 1.57M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(924.00K) 1.21M (7.40M) 11.46M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
143.57M 99.42M 2.09M (18.67M)
Minority Interest Expense
- - - -
-
Net Income
143.57M 99.42M 2.09M (18.67M)
Net Income Growth
-12.48% -30.75% -97.90% -992.97%
Net Margin Growth
+8.98% +9.27% +0.35% -4.84%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
143.57M 99.42M 2.09M (18.67M)
Preferred Dividends
- - - -
-
Net Income Available to Common
143.57M 99.42M 2.09M (18.67M)
EPS (Basic)
12.8243 9.134 0.1913 -1.7004
EPS (Basic) Growth
-8.49% -28.78% -97.91% -988.87%
Basic Shares Outstanding
11.20M 10.88M 10.93M 10.98M
EPS (Diluted)
12.7322 9.1031 0.1907 -1.7004
EPS (Diluted) Growth
-8.31% -28.50% -97.91% -991.66%
Diluted Shares Outstanding
11.28M 10.92M 10.96M 10.98M
EBITDA
233.08M 144.12M 20.28M (3.71M)
EBITDA Growth
+2.18% -38.17% -85.93% -118.31%
EBITDA Margin
+14.58% +13.44% +3.37% -0.96%

Snapshot

Average Recommendation HOLD Average Target Price 15.00
Number of Ratings 1 Current Quarters Estimate -0.43
FY Report Date 06 / 2026 Current Year's Estimate -1.98
Last Quarter’s Earnings -0.52 Median PE on CY Estimate N/A
Year Ago Earnings -0.60 Next Fiscal Year Estimate -2.76
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 1
Mean Estimate -0.43 -0.38 -1.98 -2.76
High Estimates -0.43 -0.38 -1.98 -2.76
Low Estimate -0.43 -0.38 -1.98 -2.76
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 0
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Hold

Medifast Inc. in the News